Skip to main content

Cencora Inc. Value Stock - Dividend - Research Selection

Amerisourcebergen

ISIN: US03073E1055 , WKN: 766149

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment provides pharmaceutical distribution and other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers third party logistics and outcomes research, and other services for biotechnology and other pharmaceutical manufacturers. The company\'s Other segment provides commercialization support services, including reimbursement support programs, outcomes research, contract field staffing, patient assistance and co-pay assistance programs, adherence programs, risk mitigation services, and other market access programs to pharmaceutical and biotechnology manufacturers; specialty transportation and logistics services for the biopharmaceutical industry; and animal health care products. It markets its products and services through independent sales forces and marketing organizations. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Soleo Health Appoints Joy Rowan as New Senior Vice President of Sales to Drive Strategic Growth Initiatives

2026-04-16
FRISCO, Texas, April 16, 2026 (GLOBE NEWSWIRE) -- Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, today announced the appointment of Joy Rowan, MS, MBA to the role of senior vice president, sales. Reporting to the chief commercial officer, Rowan will lead the Company’s field sales organization to accelerate commercial performance and deliver on its strategic growth initiatives. With over 25 years of industry experience and a proven track record of

Camino Corporation Commences Drilling at Costa de Cobre District-Scale IOCG Copper Discovery in Peru

2026-04-16
VANCOUVER, BC / ACCESS Newswire / April 16, 2026 /Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") is pleased to announce the commencement of a drilling campaign at its Costa de Cobre district-scale IOCG copper discovery ...

Dario Appoints Veteran Healthcare Executive John R. Palumbo to Board of Directors to Support Accelerated Commercial Scaling

2026-04-13
DarioHealth Corp. (NASDAQ: DRIO) (the "Company" or "Dario"), a leader in global digital health, today announced the appointment of John R. Palumbo to its Board of Directors. The addition reflects Dario's continued alignment of board composition with its next phase of commercial scaling.

Assessing Cencora (COR) Valuation As Short Term Momentum Cools And Long Term Returns Remain Strong

2026-04-13
Cencora (COR) has been drawing attention after recent share price volatility, with the stock down about 8% over the past month and roughly 7% over the past 3 months from its last close of $320.82. See our latest analysis for Cencora. Despite the recent weak patch in the share price, with a 30 day share price return of 8.32% and 90 day share price return of 7.25%, longer term total shareholder returns of 13.66% over 1 year and 183.05% over 5 years show that investors who stayed invested have...

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside

2026-04-12
Cencora (COR) buy rating reaffirmed for 2025: strong fundamentals, dividend growth, low payout ratio, and A-level credit.

Evercore ISI Group Maintains Outperform on Cencora, Lowers Price Target to $360

2026-04-08
Evercore ISI Group analyst John Belton maintains Cencora (NYSE:COR) with a Outperform and lowers the price target from $420 to $360.

Cencora Inc. stock underperforms Monday when compared to competitors

2026-04-06
Cencora Inc. stock underperforms Monday when compared to competitors

Is Medline Inc. (MDLN) A Good Stock To Buy Now?

2026-04-06
Is MDLN a good stock to buy? We came across a bullish thesis on Medline Inc. on The Pursuit of Compounding’s Substack. In this article, we will summarize the bulls’ thesis on MDLN. Medline Inc.’s share was trading at $41.36 as of March 27th. MDLN’s trailing and forward P/E were 29.91 and 29.24 respectively according to Yahoo Finance. Medline Industries (MDLN) […]

Cencora Inc. stock outperforms competitors on strong trading day

2026-04-02
Cencora Inc. stock outperforms competitors on strong trading day

2 S&P 500 Stocks with Exciting Potential and 1 We Ignore

2026-04-02
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.